Nektar Therapeutics Available-for-sale Securities
Nektar Therapeutics (NKTR) had Available-for-sale Securities of $2.00 billion as of 2018-06-30, per its 10-Q filed 2018-08-09.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecurities · last filed 2018-08-09
- 2018-06-30: Available-for-sale Securities $2.00B.
- 2018-03-31: Available-for-sale Securities $297.79M.
- 2017-12-31: Available-for-sale Securities $347.33M.
- 2017-09-30: Available-for-sale Securities $382.01M.
| Period end | Available-for-sale Securities | Available-for-sale Securities as first filed |
|---|---|---|
| 2018-06-30 | $2.00B 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $297.79M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $347.33M 10-Q · filed 2018-08-09 | |
| 2017-09-30 | $382.01M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $291.63M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $335.61M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $330.71M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $187.29M 10-Q · filed 2016-11-04 | |
| 2016-06-30 | $216.25M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $212.85M 10-Q · filed 2016-05-04 | |
| 2015-12-31 | $250.44M 10-K · filed 2017-03-01 | |
| 2015-09-30 | $246.07M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $230.86M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $171.35M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $225.46M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $204.63M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $247.44M 10-Q · filed 2014-08-01 | |
| 2014-03-31 | $251.63M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $197.96M 10-K · filed 2015-02-26 | |
| 2013-09-30 | $121.94M 10-Q · filed 2013-11-07 | |
| 2013-06-30 | $172.46M 10-Q · filed 2013-08-09 | |
| 2012-12-31 | $252.76M 10-K · filed 2014-02-27 | $251.76M 10-K · filed 2013-03-01 |
| 2012-09-30 | $318.96M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $340.96M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $350.36M 10-Q · filed 2012-05-04 | |
| 2011-12-31 | $399.62M 10-K · filed 2013-03-01 | |
| 2011-09-30 | $414.96M 10-Q · filed 2011-11-04 | |
| 2011-06-30 | $470.22M 10-Q · filed 2011-08-05 | |
| 2010-12-31 | $298.18M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |